Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Vorozole safe and effective in phase II EORTC study

Feb. 11, 1998

GeneMedicine and Corange progress in cancer alliance

Feb. 11, 1998

Novel mitomycin C derivative reported by Sagami

Feb. 11, 1998

Clinical results of LHRH antagonist in BPH and prostate cancer

Feb. 10, 1998

Association between plasma IGF-I and prostate cancer

Feb. 10, 1998

Atlantic's 2-5A antisense compound targets telomerase

Feb. 9, 1998

Magic bullet for cancer treatment finally found?

Feb. 9, 1998

First results described for novel aromatase inhibitor in phase I

Feb. 6, 1998

Ilex initiates phase I testing of intoplicine

Feb. 6, 1998

DEHOP enters phase I for NHL

Feb. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...